1. Home
  2. MCHX vs CLNN Comparison

MCHX vs CLNN Comparison

Compare MCHX & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.79

Market Cap

67.3M

ML Signal

HOLD

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.13

Market Cap

79.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MCHX
CLNN
Founded
2003
2012
Country
United States
United States
Employees
N/A
79
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.3M
79.1M
IPO Year
2003
N/A

Fundamental Metrics

Financial Performance
Metric
MCHX
CLNN
Price
$1.79
$5.13
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
18.9K
51.4K
Earning Date
05-14-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$90,291,000.00
N/A
Revenue This Year
$5.37
$17.64
Revenue Next Year
N/A
$19,516.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.32
$3.30
52 Week High
$2.14
$13.50

Technical Indicators

Market Signals
Indicator
MCHX
CLNN
Relative Strength Index (RSI) 57.56 33.45
Support Level $1.54 $4.48
Resistance Level $1.92 $6.61
Average True Range (ATR) 0.10 0.33
MACD -0.00 -0.09
Stochastic Oscillator 61.54 2.73

Price Performance

Historical Comparison
MCHX
CLNN

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: